English  |  正體中文  |  简体中文  |  總筆數 :2856753  
造訪人次 :  53874354    線上人數 :  1119
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"lu y s"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 141-150 / 467 (共47頁)
<< < 10 11 12 13 14 15 16 17 18 19 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-08-16T03:26:37Z PI3K inhibitor provides durable response in metastatic metaplastic carcinoma of the breast: A hidden gem in the BELLE-4 study Yang M.-H.; I-CHUN CHEN; Lu Y.-S.
臺大學術典藏 2021-08-16T03:26:37Z Adiposity, inflammation, and breast cancer pathogenesis in Asian Women Iyengar N.M.; I-CHUN CHEN; Zhou X.K.; Giri D.D.; Falcone D.J.; Winston L.A.; Wang H.; Williams S.; Lu Y.-S.; Hsueh T.-H.; Cheng A.-L.; Hudis C.A.; Lin C.-H.; Dannenberg A.J.
臺大學術典藏 2021-08-16T03:26:36Z Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western Populations Chen C.-H.; Lu Y.-S.; Cheng A.-L.; Huang C.-S.; Kuo W.-H.; Wang M.-Y.; Chao M.; I-CHUN CHEN; Kuo C.-W.; Lu T.-P.; Lin C.-H.
臺大學術典藏 2021-08-16T03:26:35Z Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival Chen T.W.-W.; Jan I.-S.; Chang D.-Y.; Lin C.-H.; I-CHUN CHEN; Chen H.-M.; Cheng A.-L.; Lu Y.-S.
臺大學術典藏 2021-08-16T03:26:32Z Tumor-infiltrating lymphocyte abundance and programmed death-ligand 1 expression in metaplastic breast carcinoma: implications for distinct immune microenvironments in different metaplastic components Lien H.-C.; Lee Y.-H.; I-CHUN CHEN; Lin C.-H.; Chen T.W.-W.; Lu Y.-T.; Lu Y.-S.
臺大學術典藏 2021-08-16T03:26:30Z Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients I-CHUN CHEN; Hu F.-C.; Lin C.-H.; Huang S.-M.; Chang D.-Y.; Cheng A.-L.; Lu Y.-S.
臺大學術典藏 2021-08-12T04:01:30Z Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy Kuo Y.-H.; Lin C.-H.; Shau W.-Y.; Chen T.-J.; YANG SHIH-HUNG; Huang S.-M.; Hsu C.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏 2021-08-11T03:46:53Z Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma Lu Y.-S.; Kashida Y.; Kulp S.K.; Wang Y.-C.; Wang D.; Hung J.-H.; Tang M.; ZHONG-ZHE LIN; Chen T.-J.; Cheng A.-L.; Chen C.-S.
臺大學術典藏 2021-08-11T03:46:47Z The impact of diabetes mellitus on prognosis of early breast cancer in Asia Chen W.-W.; Shao Y.-Y.; Shau W.-Y.; ZHONG-ZHE LIN; Lu Y.-S.; Chen H.-M.; Kuo R.N.C.; Cheng A.-L.; Lai M.-S.
臺大學術典藏 2021-08-11T03:46:47Z Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma Shao Y.-Y.; ZHONG-ZHE LIN; Hsu C.; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.

顯示項目 141-150 / 467 (共47頁)
<< < 10 11 12 13 14 15 16 17 18 19 > >>
每頁顯示[10|25|50]項目